J A Kanis1, E V McCloskey, M N Beneton. Show Affiliations » 1. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK.
Abstract
Entities: Chemical Disease
Mesh: See more » AgedChronic Kidney Disease-Mineral and Bone Disorder/drug therapyChronic Kidney Disease-Mineral and Bone Disorder/etiologyFemaleHumansHydroxycholecalciferols/therapeutic useHyperparathyroidism/complicationsKidney Failure, Chronic/complicationsMaleOsteoporosis/etiologyRenal DialysisVitamin D/analogs & derivativesVitamin D/therapeutic useVitamin D Deficiency/complications
Substances: See more » HydroxycholecalciferolsVitamin Dalfacalcidol
Year: 1997 PMID: 9536328 DOI: 10.1007/bf03194368
Source DB: PubMed Journal: Osteoporos Int ISSN: 0937-941X Impact factor: 4.507